TP-CSO: A Triptolide Prodrug for Pancreatic Cancer Treatment
Sign Up to like & getrecommendations! Published in 2022 at "Molecules"
DOI: 10.3390/molecules27123686
Abstract: Triptolide (TP) is a potential drug candidate for the treatment of cancer, but its use was hampered by its systemic toxicity and poor water solubility. Hence, a TP-CSO prodrug was synthesized by conjugating TP to… read more here.
Keywords: cso; triptolide prodrug; cso triptolide; prodrug pancreatic ... See more keywords